Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Mar 8, 2011

Premium

Anagnostics recently launched the latest generation of its Hyborg system. The Austrian firm said the upgraded system includes "more intuitive" control and analysis software, as well as "easier handling" of assays.

The Hyborg system supports Anagnostics' cylindrical Hybcell arrays. The system includes a thermal cycler, a hybridization station, and a scanner.


Asper Biotech has updated its congenital stationary night blindness genetic test. The new version includes two additional genes – GRK1 and TRPM1, associated with CSNB. The Estonian fim's CSNB microarray now covers the analysis of 11 genes – RHO, PDE6B, GNAT1, CABP4, GRM6, SAG, NYX, CACNA1F, CACNA2D, GRK1, TRPM1 – and detects 159 mutations. The previous version of the test detected 126 mutations.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.